↓ Skip to main content

American Association for Cancer Research

Robust Antitumor Activity and Low Cytokine Production by Novel Humanized Anti-CD19 CAR T CellsAnti-CD19 CAR with Favorable Efficacy to Toxicity Balance

Overview of attention for article published in Molecular Cancer Therapeutics, February 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
3 news outlets
blogs
1 blog
twitter
78 X users

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
28 Mendeley
Title
Robust Antitumor Activity and Low Cytokine Production by Novel Humanized Anti-CD19 CAR T CellsAnti-CD19 CAR with Favorable Efficacy to Toxicity Balance
Published in
Molecular Cancer Therapeutics, February 2021
DOI 10.1158/1535-7163.mct-20-0476
Pubmed ID
Authors

Alka Dwivedi, Atharva Karulkar, Sarbari Ghosh, Srisathya Srinivasan, Bajarang Vasant Kumbhar, Ankesh Kumar Jaiswal, Atish Kizhakeyil, Sweety Asija, Afrin Rafiq, Sushant Kumar, Albeena Nisar, Deepali Pandit Patil, Minal Vivek Poojary, Hasmukh Jain, Shripad D. Banavali, Steven L. Highfill, David F. Stroncek, Nirali N. Shah, Terry J. Fry, Gaurav Narula, Rahul Purwar

X Demographics

X Demographics

The data shown below were collected from the profiles of 78 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 28 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 14%
Researcher 3 11%
Student > Bachelor 2 7%
Student > Master 2 7%
Other 1 4%
Other 3 11%
Unknown 13 46%
Readers by discipline Count As %
Medicine and Dentistry 7 25%
Biochemistry, Genetics and Molecular Biology 2 7%
Immunology and Microbiology 2 7%
Agricultural and Biological Sciences 1 4%
Unspecified 1 4%
Other 2 7%
Unknown 13 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 84. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 March 2024.
All research outputs
#510,250
of 25,559,053 outputs
Outputs from Molecular Cancer Therapeutics
#54
of 4,071 outputs
Outputs of similar age
#15,220
of 452,052 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#1
of 68 outputs
Altmetric has tracked 25,559,053 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,071 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.9. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 452,052 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 68 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.